Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety

BACKGROUND: Hepatocyte growth factor (HGF) stimulates hepatocyte proliferation, and also acts as an anti-apoptotic factor. Therefore, HGF is a potential therapeutic agent for treatment of fatal liver diseases. We performed a translational medicine protocol with recombinant human HGF (rh-HGF), includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ido, Akio, Moriuchi, Akihiro, Numata, Masatsugu, Murayama, Toshinori, Teramukai, Satoshi, Marusawa, Hiroyuki, Yamaji, Naohisa, Setoyama, Hitoshi, Kim, Il-Deok, Chiba, Tsutomu, Higuchi, Shuji, Yokode, Masayuki, Fukushima, Masanori, Shimizu, Akira, Tsubouchi, Hirohito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112439/
https://www.ncbi.nlm.nih.gov/pubmed/21548996
http://dx.doi.org/10.1186/1479-5876-9-55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112439/
https://www.ncbi.nlm.nih.gov/pubmed/21548996
http://dx.doi.org/10.1186/1479-5876-9-55

Ejemplares similares